Skip to main content
Clinical Trials/TCTR20180926003
TCTR20180926003
Completed
N/A

asal High Flow Versus Conventional Oxygen Therapy in Emergency Department Patients With Asthma Exacerbation and Hypoxemia: A Randomized Controlled Trial

Siriraj Hospital0 sites50 target enrollmentSeptember 26, 2018
Conditionsasthma

Overview

Phase
N/A
Intervention
Not specified
Conditions
asthma
Sponsor
Siriraj Hospital
Enrollment
50
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 26, 2018
End Date
February 25, 2020
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\.Patients with age of 18 years or older
  • 2\.Patients who previously diagnosed with asthma according to GINA guideline
  • 3\.Patients who present with symptoms compatible with exacerbation according to GINA guideline (progressive increase in symptoms of shortness of breath, cough, wheezing or chest tightness and progressive decrease in lung function)
  • 4\.Patients with hypoxemia defined as SpO2 at room air of less than 95%

Exclusion Criteria

  • 1\.Patients with respiratory failure; defined as respiratory rate \>35 breaths/min, SpO2 \<90% despite oxygen supplement or signs of increased work of breathing, as observed by use of accessory muscles and abdominal asynchrony.
  • 2\.Patients with hemodynamic compromise (blood pressure \<90/60 mmHg) despite intravenous fluid resuscitation
  • 3\.Patients with a Glasgow Coma Scale score less than 13
  • 4\.Patients with contraindications to the use of equipment with positive airway pressure
  • 5\.Patients previously diagnosed with COPD, lung cancer, myocardial infarction (within 3 months), renal insufficiency requiring hemodialysis
  • 6\.Patients previously smoking \> 5 pack/year
  • 7\.Patients concurrently diagnosed with other lower airway conditions such as pneumonia, pulmonary edema
  • 8\.Patients who decline to participate
  • 9\.Pregnant patients

Outcomes

Primary Outcomes

Not specified

Similar Trials